Please login to the form below

Not currently logged in
Email:
Password:

Makara Health launches compliance training division

Collaborates with Dr Nick Broughton on the new programme

Learning and development

Healthcare communications and education agency Makara Health has launched a new ethics and code compliance training as a division of its learning and development portfolio.

The move is a partnership with ethics and compliance trainer Dr Nick Broughton and the agency aims to “focus on tapping into something deeper than just upskilling” so that it can “truly effect change - either to a situation or personal ability”.

Makara Health founder and managing director Louise Sharp said: “At Makara Health, our learning and development programmes have a reputation for being thought provoking and a bit different.

“Our new Ethics and Code Compliance division with Dr Nick Broughton fits entirely with this ethos.”

From May, Makara Health and Broughton will offer a range of courses on compliance within the ABPI and EFPIA codes of practice, aimed at audiences from senior managers to those involved with marketing materials.

Dr Broughton said: “ I know from client feedback that what I offer is different and engaging, which is why I chose to work with Makara as it aligns to their way of thinking.

“Attendees to my courses often find themselves bemused by actually enjoying compliance training. I work hard to make my sessions fun and interactive rather than a case of learning the ABPI Code by rote.”

Alongside the programme, Broughton is offering a specific course for pharmaceutical physicians covering topics such as clinical research, drug safety, and digital and social media in relation to code compliance.

Article by
Gemma Jones

3rd April 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ahair@onyxhealth.com

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...